Neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and periostin: Novel urinary biomarkers in diabetic nephropathy

doi:10.5527/wjn.v13.i4.98880

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (560)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

HTML

279

Figures (1-1)

Tables (1-5)

Sum=469

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=75

Dec 25, 2024 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Nephrol. Dec 25, 2024; 13(4): 98880
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.98880

Neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and periostin: Novel urinary biomarkers in diabetic nephropathy

Sakthivadivel Varatharajan, Vishakha Jain, Anand K Pyati, Charan Neeradi, Kotha Sugunakar Reddy, Janardhana Reddy Pallavali, Ilakkiya Priya Pandiyaraj, Archana Gaur

Sakthivadivel Varatharajan, Vishakha Jain, Charan Neeradi, Janardhana Reddy Pallavali, Ilakkiya Priya Pandiyaraj, Department of General Medicine, All India Institute of Medical Sciences-Bibinagar, Hyderabad 508126, Telangana, India

Anand K Pyati, Department of Biochemistry, All India Institute of Medical Sciences-Bibinagar, Hyderabad 508126, Telangana, India

Kotha Sugunakar Reddy, Department of General Medicine, Neelima Institute of Medical Sciences, Hyderabad 500088, Telangana, India

Archana Gaur, Department of Physiology, All India Institute of Medical Sciences-Bibinagar, Hyderabad 508126, Telangana, India

Author contributions: Varatharajan S conceived, designed, and coordinated the study, participated in the acquisition and interpretation of data, and drafted the manuscript; Jain V, Pyati AK, Neeradi C, and Reddy KS participated in the acquisition, interpretation of the data, and drafted the initial manuscript; Pallavali JR, Pandiyaraj IP, and Gaur A participated in the analysis, interpretation of the data and revised the article critically for important intellectual content; all of the authors read and approved the final version of the manuscript to be published.

Supported by All India Institute of Medical Sciences-Bibinagar, No: AIIMS/BBN/Research/IM-F/2022/20.

Institutional review board statement: This study was reviewed and approved by the Ethics Committee of All India Institute of Medical Sciences-Bibinagar Institutional Review Board, No. AIIMS/BBN/IEC/SEP/2021/93-A.

Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrolment.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at vsakthivadivel28@gmail.com.

STROBE statement: The authors have read the STROBE Statement-checklist of items-and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Sakthivadivel Varatharajan, MD, Additional Professor, Department of General Medicine, All India Institute of Medical Sciences-Bibinagar, Bibinagar, Hyderabad 508126, Telangana, India. vsakthivadivel28@gmail.com

Received: July 8, 2024
Revised: September 25, 2024
Accepted: October 20, 2024
Published online: December 25, 2024
Processing time: 122 Days and 0.3 Hours

Core Tip

Core Tip: Diabetic nephropathy (DN) is a leading cause of chronic kidney disease. Novel urinary biomarkers are useful for detecting DN at an early stage, facilitating timely intervention. Among these, Neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and periostin have shown promise as early detection markers for DN.